CTAG2 antibody (AA 121-210)
-
- Target See all CTAG2 Antibodies
- CTAG2 (Cancer/testis Antigen 2 (CTAG2))
-
Binding Specificity
- AA 121-210
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This CTAG2 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Cross-Reactivity
- Human
- Purification
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CTAG2
- Isotype
- IgG
-
-
- Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Expiry Date
- 12 months
-
- Target
- CTAG2 (Cancer/testis Antigen 2 (CTAG2))
- Alternative Name
- CTAG2 (CTAG2 Products)
- Background
-
Synonyms: CT2, ESO2, CAMEL, CT6.2, CT6.2a, CT6.2b, LAGE-1, LAGE2B, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1, CTAG2, LAGE1
Background: Testis and very low level in placenta and in some uterus samples. Observed in 25-50 % of tumor samples of melanomas, non-small-cell lung carcinomas, bladder, prostate and head and neck cancers.
- Gene ID
- 30848
- UniProt
- O75638
-